利帕舒地尔对MCP-1激活的小鼠结膜下免疫细胞运动的影响
本研究探讨Rho激酶抑制剂利帕舒地尔对单核细胞趋化蛋白-1(MCP-1)激活的免疫细胞的影响。通过单细胞RNA测序和免疫细胞化学鉴定LysM阳性细胞为巨噬细胞,利用多光子显微镜观察MCP-1加载后LysM-eGFP敲入小鼠结膜下细胞运动,并采用Boyden小室实验检测THP-1和RAW264.7细胞迁移。结果显示MCP-1显著增加LysM阳性细胞速度和数量,利帕舒地尔预处理显著降低细胞速度(从6.48±3.87降至2.97±1.59 µm/min,P<0.0001),且10 µM利帕舒地尔几乎完全抑制MCP-1诱导的THP-1和RAW264.7细胞迁移。结论提示利帕舒地尔可能具有预防青光眼滤过术后过度伤口愈合的治疗潜力。
要点
- MCP-1显著增加小鼠结膜下LysM阳性巨噬细胞的速度和数量。
- 利帕舒地尔预处理显著降低MCP-1激活的巨噬细胞速度,但不显著改变细胞数量。
- 10 µM利帕舒地尔几乎完全抑制MCP-1诱导的THP-1和RAW264.7细胞迁移。
核心结论
- 利帕舒地尔在体内成像和体外实验中均减弱MCP-1激活的巨噬细胞行为。
- 利帕舒地尔可能具有预防青光眼滤过术后过度伤口愈合的治疗潜力。
研究设计与样本
- 研究采用单细胞RNA测序和免疫细胞化学鉴定LysM阳性细胞类型。
- 使用LysM-eGFP敲入小鼠在多光子显微镜下观察MCP-1加载后结膜下细胞运动。
- 体外采用Boyden小室实验检测THP-1和RAW264.7细胞迁移,并检验利帕舒地尔的效果。
主要发现
- LysM阳性细胞被鉴定为小鼠结膜下组织中的巨噬细胞。
- MCP-1显著增加LysM阳性细胞的速度和数量, compared with the intact state。
- 利帕舒地尔预处理显著降低细胞速度从6.48 ± 3.87到2.97 ± 1.59 µm/min(P < 0.0001, Welch's t-test),但细胞数量变化不显著。
- Boyden小室实验显示MCP-1诱导THP-1和RAW264.7细胞迁移,10 µM利帕舒地尔几乎完全抑制该迁移。
关键数值与推荐
- 利帕舒地尔降低LysM阳性细胞速度:从6.48 ± 3.87到2.97 ± 1.59 µm/min,P < 0.0001(Welch's t-test)。
- 10 µM利帕舒地尔几乎完全抑制MCP-1诱导的THP-1和RAW264.7细胞迁移。
临床怎么用
- 利帕舒地尔可能用于青光眼滤过术后预防过度伤口愈合,但需进一步临床验证。
- 针对MCP-1激活的巨噬细胞行为可能是减少术后瘢痕化的潜在靶点。
局限性
- 研究仅在小鼠和细胞系中进行,尚未在人体验证。
- 利帕舒地尔对细胞数量变化无显著影响,其具体机制未完全阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The postoperative wound-healing response significantly affects the outcome of glaucoma filtering surgery. Understanding this response at the cellular level is crucial. This study investigated the effects of the Rho kinase inhibitor ripasudil on immune cells activated by monocyte chemoattractant protein-1 (MCP-1), a known risk factor for glaucoma filtering surgery failure. METHODS: Single-cell RNA sequencing and immunocytochemical analyses were performed to identify the type of lysozyme M (LysM)-positive cells. LysM-eGFP knock-in mice were observed using multiphoton microscopy after MCP-1 loading. Raw image data were analyzed with Imaris software to quantify the number and velocity of LysM-positive cells. In the Boyden chamber assay, THP-1 and RAW264.7 cells were loaded into the upper chambers, with MCP-1 in the lower wells acting as a chemoattractant. The effect of ripasudil was examined in each experiment. RESULTS: LysM-positive cells were identified as macrophages in mouse subconjunctival tissue. MCP-1 significantly increased both the velocity and number of LysM-positive cells compared with the intact state. Pretreatment with ripasudil significantly reduced cell velocity from 6.48 ± 3.87 to 2.97 ± 1.59 µm/min (P < 0.0001, Welch's t-test), although the change in cell number was not significant. The Boyden chamber assay showed that MCP-1 induced THP-1 and RAW264.7 cell migration, which was almost completely inhibited by 10 µM ripasudil. CONCLUSIONS: Ripasudil attenuated MCP-1-activated macrophage behavior in both intravital imaging and in vitro experiments. These findings suggest that ripasudil may have therapeutic potential for preventing excessive wound healing after glaucoma filtering surgery.
引用
- Nakamura K, Funagura N, Kojima S, et al. Effects of Ripasudil on Mouse Subconjunctival Immune Cell Motility Activated by Monocyte Chemoattractant Protein-1. Invest Ophthalmol Vis Sci. 2026. PMID: 42274198. doi:10.1167/iovs.67.6.20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。